Marta Cuenca Lopera

Dr. Marta Cuenca Lopera

Division Laboratories, Pharmacy and Biomedical Genetics, Center for Translational Immunology, section Tumor Immunology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2019 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
PCPablo F. Cañete
Pablo F. Cañete
RSRebecca A. Sweet
Rebecca A. Sweet
PGPaula Gonzalez-Figueroa
Paula Gonzalez-Figueroa
IPIlenia Papa
Ilenia Papa
NONaganari Ohkura
Naganari Ohkura
CVCarola G. Vinuesa
Carola G. Vinuesa
Mucosal lymphoid tissues such as human tonsil are colonized by bacteria and exposed to ingested and inhaled antigens, requiring tight regulation of immune responses. Antibody responses are regulated by follicular helper T (TFH) cells and FOXP3+ follicular regulatory T (TFR) cells. Here we describe a subset of human tonsillar follicular T cells identified by expression of TFH markers and CD25 that are the main source of follicular T (TF) cell–derived IL-10. Despite lack of FOXP3 expression, CD25+ TF cells resemble T reg cells in high CTLA4 expression, low IL-2 production, and their ability to repress T cell proliferation. CD25+ TF cell–derived IL-10 dampens induction of B cell class-switching to IgE. In children, circulating total IgE titers were inversely correlated with the frequencies of tonsil CD25+ TF cells and IL-10–producing TF cells but not with total T reg cells, TFR, or IL-10–producing T cells. Thus, CD25+ TF cells emerge as a subset with unique T and B cell regulatory activities that may help prevent atopy.

1 July 2019 in Clinical Immunology
Verified
Journal Article
Closed access
MLMarta Cuenca Lopera
Marta Cuenca Lopera
JSJordi Sintes
Jordi Sintes
ÁLÁrpád Lányi
Árpád Lányi
Pablo EngelPablo Engel
Pablo Engel

1 January 2013 in Frontiers in Immunology
Verified
Journal Article
Open access
JSJose de Salort
Jose de Salort
MLMarta Cuenca Lopera
Marta Cuenca Lopera
CTCox Terhorst
Cox Terhorst
Pablo EngelPablo Engel
Pablo Engel
XRXavier Romero
Xavier Romero
The Signaling Lymphocyte Activation Molecule Family (SLAMF) genes, which encode cell-surface receptors that modulate innate and adaptive immune responses, lay within a genomic region of human and mouse chromosome 1 that confers a predisposition for the development of systemic lupus erythematosus (SLE). Herein, we demonstrate that the SLAMF member Ly9 arises as a novel receptor contributing to the reinforcement of tolerance. Specifically, Ly9-deficient mice spontaneously developed features of systemic autoimmunity such as the production of anti-nuclear antibodies (ANA), -dsDNA, and -nucleosome autoantibodies, independently of genetic background [(B6.129) or (BALB/c.129)]. In aged (10- to 12-month-old) Ly9−/− mice key cell subsets implicated in autoimmunity were expanded, e.g., T follicular helper (Tfh) as well as germinal center (GC) B cells. More importantly, in vitro functional experiments showed that Ly9 acts as an inhibitory receptor of IFN-γ producing CD4+ T cells. Taken together, our findings reveal that the Ly9 receptor triggers cell intrinsic safeguarding mechanisms to prevent a breach of tolerance, emerging as a new non-redundant inhibitory cell-surface receptor capable of disabling autoantibody responses.

19 May 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
TKThomas Kimman
Thomas Kimman
MLMarta Cuenca Lopera
Marta Cuenca Lopera
RTRalph G. Tieland
Ralph G. Tieland
DRDedeke Rockx-Brouwer
Dedeke Rockx-Brouwer
JJJasmijn Janssen
Jasmijn Janssen
VPVictor Peperzak
Victor Peperzak
Clinical responses with chimeric antigen receptor (CAR) T cells are encouraging, but primary resistance and relapse after therapy prevent durable remission in many patients with cancer, with apoptosis resistance in cancer cells that limits killing by CAR T cells being a potential cause. Here we aim to boost tumor cell apoptosis induced by CAR T cells and find that anti-B cell maturation antigen (BCMA) CAR T cells over-expressing a granzyme B-NOXA fusion protein show improved killing of multiple myeloma (MM) cells in vitro and in xenograft mouse models in vivo. Mechanistically, such an enhancement is mediated by localizing NOXA to cytotoxic granules that are released into cancer cells upon contact. In MM cells, inhibition of MCL-1, an anti-apoptotic factor, by its natural ligand NOXA effectively induces apoptosis. Our data thus show that endowing granzyme B-NOXA expression to CAR T cells improves their killing efficacy, thereby presenting a potential generalizable enhancement for CAR T-mediated anti-cancer immunity.

8 May 2021 in Cancers
Verified
Journal Article
Open access
PDF file
MLMarta Cuenca Lopera
Marta Cuenca Lopera
VPVictor Peperzak
Victor Peperzak
B-cell malignancies arise from different stages of B-cell differentiation and constitute a heterogeneous group of cancers including B-cell lymphomas, B-cell leukemias, and plasma cell dyscrasias

30 July 2025 in iScience
Verified
Journal Article
Open access
SRSonia Aristin Revilla
Sonia Aristin Revilla
ACAlessandro Cutilli
Alessandro Cutilli
ECEugenia Cambiaso
Eugenia Cambiaso
DRDedeke Rockx-Brouwer
Dedeke Rockx-Brouwer
CFCynthia Lisanne Frederiks
Cynthia Lisanne Frederiks
MLMarta Cuenca Lopera
Marta Cuenca Lopera
Hydrogel-based 3D culture systems are increasingly used for preclinical evaluation of cell-based immunotherapies, including chimeric antigen receptor T (CAR-T) cells. However, hydrogel properties can influence T cell behavior, potentially affecting interpretation of immunotherapy studies. We assessed CD4+ T and CAR-T cell responses in two chemically undefined matrices—Matrigel and basement membrane extract (BME)— and in a synthetic nanofibrillar cellulose (NFC) hydrogel. Although NFC was mechanically stiffer, T cell activation and proliferation were higher in NFC than in Matrigel or BME. Murine CD4+ T cells acquired a regulatory phenotype in Matrigel and BME but not in NFC. Similarly, CAR-T cell function was reduced in Matrigel and BME but maintained in NFC. These findings underscore how matrix composition can shape T cell responses in 3D culture. NFC provides a chemically defined alternative that preserves T cell activity, supporting its use in more accurate preclinical testing of immunotherapies.